5-Amino-1MQ Mechanism of Action (Preclinical)
5-Amino-1MQ is a membrane-permeable small-molecule inhibitor targeting nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular energy regulation and epigenetic remodeling. In vitro and rodent models demonstrate that targeted NNMT inhibition prevents the irreversible methylation of nicotinamide, preserving critical substrate pools for NAD+ synthesis and modulating mitochondrial oxidative pathways. This technical overview outlines the biochemical targets, enzymatic kinetics, and downstream metabolic cascades governed by 5-Amino-1MQ in laboratory settings.
Quick answer
5-Amino-1MQ is a membrane-permeable small-molecule inhibitor targeting nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular energy regulation and epigenetic remodeling. In vitro and rodent models demonstrate that targeted NNMT inhibition prevents the irreversible methylation of nicotinamide, preserving critical substrate pools for NAD+ synthesis and modulating mitochondrial oxidative pathways. This technical overview outlines the biochemical targets, enzymatic kinetics, and downstream metabolic cascades governed by 5-Amino-1MQ in laboratory settings.
Key takeaways
- Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme responsible for catalyzing the transfer of a methyl group from the universal donor S-adenosylmethionine (SAM) to nicotinamide (NAM), producing S-adenosylhomocysteine (SAH) and 1-methylnicotinamide (MNA).
- Chemically designated as 5-amino-1-methylquinolinium, [5-Amino-1MQ](/research-peptides/5-amino-1mq) is a low-molecular-weight quinoline derivative optimized for cell-membrane permeability and structural compatibility with the active site of NNMT.
- The primary downstream consequence of NNMT inhibition is the preservation of intracellular nicotinamide (NAM).
- Beyond its direct effect on cellular [NAD+](/research-peptides/nad-plus) levels, the [5-amino-1mq](/research-peptides/5-amino-1mq) mechanism of action heavily influences cellular methyl donor availability.
Enzymatic Target: Nicotinamide N-Methyltransferase (NNMT) Overview
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme responsible for catalyzing the transfer of a methyl group from the universal donor S-adenosylmethionine (SAM) to nicotinamide (NAM), producing S-adenosylhomocysteine (SAH) and 1-methylnicotinamide (MNA). Under homeostatic conditions, this enzymatic reaction serves as a major pathway for terminal elimination of excess nicotinamide from the intracellular environment, as MNA cannot be recycled back into the NAD+ salvage pathway and is ultimately excreted.
In metabolic research, high NNMT expression has been consistently observed in white adipose tissue, liver tissue, and specific oncogenic cell lineages. Elevated NNMT activity acts as a biochemical sink, depleting cellular NAM pools and consuming SAM, which in turn reduces the availability of substrates required for nicotinamide adenine dinucleotide (NAD+) biosynthesis and histone methylation. Research evaluating 5-Amino-1MQ centers on its capacity to selectively bind and block the active site of NNMT, effectively slowing this metabolic drain in experimental models.
Molecular Structure and Competitive Inhibition Kinetics
Chemically designated as 5-amino-1-methylquinolinium, 5-Amino-1MQ is a low-molecular-weight quinoline derivative optimized for cell-membrane permeability and structural compatibility with the active site of NNMT. Biochemical binding assays indicate that 5-Amino-1MQ functions as a charge-bearing, reversible inhibitor that competes directly with nicotinamide for binding within the catalytic pocket of the enzyme.
Kinetic studies utilizing recombinant human and murine NNMT enzymes report low micromolar IC50 values (typically ranging between 1.2 to 2.5 µM). Structural modeling reveals that the methylquinolinium ring system engages in pi-stacking interactions with active-site aromatic residues, while the 5-amino substitution forms hydrogen bonds that stabilize the enzyme-inhibitor complex. Because 5-Amino-1MQ exhibits high selectivity for NNMT over other methyltransferases (such as COMT or DNMT1), investigators can isolate NNMT-dependent signaling pathways without non-specific off-target epigenetic disruption.
Intracellular NAD+ Salvage Pathway Upregulation
The primary downstream consequence of NNMT inhibition is the preservation of intracellular nicotinamide (NAM). Under normal physiological conditions, cellular NAD+ levels are maintained largely through the salvage pathway, wherein NAM is converted to nicotinamide mononucleotide (NMN) by the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). NMN is subsequently converted to NAD+ by NMNAT enzymes.
When NNMT is active, a significant fraction of NAM is methylated to MNA and removed from this cycle. Preclinical assays demonstrate that application of 5-Amino-1MQ blocks MNA formation, thereby elevating intracellular free NAM concentration. This increase in substrate availability drives increased flux through NAMPT, raising steady-state NAD+ concentrations in cultured adipocytes and myocytes without requiring exogenous NAD+ precursors. Researchers utilizing NAD+ pathway models frequently employ 5-Amino-1MQ to evaluate endogenous salvage kinetics.
Preservation of S-Adenosylmethionine (SAM) and Epigenetic Methylation
Beyond its direct effect on cellular NAD+ levels, the 5-amino-1mq mechanism of action heavily influences cellular methyl donor availability. NNMT is one of the highest-capacity consumers of S-adenosylmethionine (SAM) in adipocytes and hepatocytes. Excessive NNMT activity alters the SAM-to-SAH ratio, a critical metric governing the activity of histone methyltransferases (HMTs) and DNA methyltransferases (DNMTs).
In vitro studies show that inhibiting NNMT with 5-Amino-1MQ reduces SAM consumption, restoring the intracellular SAM/SAH balance. Preclinical rodent models of metabolic dysfunction suggest that this normalization of methyl donor pools alters chromatin accessibility at specific genomic loci governing lipid transport and oxidative metabolism. By preventing SAM depletion, 5-Amino-1MQ enables researchers to examine the interplay between intermediate metabolism and epigenetic regulation in metabolic tissues.
Mitochondrial Bioenergetics and Oxidative Phosphorylation
The elevation of intracellular NAD+ driven by 5-Amino-1MQ directly impacts NAD+-dependent enzymes, most notably the sirtuin family of protein deacetylases. Increased NAD+ availability activates SIRT1 (nuclear/cytosolic) and SIRT3 (mitochondrial), triggering a cascade of deacetylation events on key metabolic transcription factors and mitochondrial enzymes.
SIRT1 activation leads to the deacetylation and functional stimulation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis. Concurrently, SIRT3 deacetylation of complex I subunits and succinate dehydrogenase in the electron transport chain enhances baseline oxygen consumption rate (OCR) and ATP production efficiency. In preclinical cell culture assays, researchers measure these parameter changes using respirometry to quantify improvements in cellular bioenergetics under conditions of mitochondrial research.
Adipocyte Remodeling and Fat-Metabolism Pathways
In animal models of diet-induced obesity (DIO), elevated NNMT expression in white adipose tissue correlates strongly with reduced metabolic rate and hypertrophic adipocyte expansion. Administration of 5-Amino-1MQ in preclinical mouse studies has demonstrated significant reductions in adipocyte volume and overall fat mass accumulation, despite unchanged caloric intake.
At the tissue level, 5-Amino-1MQ drives a transcriptomic shift toward increased fatty acid beta-oxidation. Gene expression analyses reveal upregulation of carnitine palmitoyltransferase 1A (CPT1a), acyl-CoA oxidase 1 (ACOX1), and uncoupling protein 1 (UCP1) in adipose tissue beds. These findings suggest that NNMT inhibition promotes a metabolic transition wherein white adipocytes adopt oxidative characteristics typical of beige adipocytes, providing a valuable framework for studying obesity mechanisms and lipid storage dynamics.
Comparative Analysis: NNMT Inhibitors vs. Direct AMPK and PPAR Modulators
When designing preclinical protocols to evaluate metabolic flux, researchers often compare 5-Amino-1MQ against other class-leading metabolic regulators. While 5-Amino-1MQ acts as an upstream enzymatic inhibitor targeting the NAD+/SAM salvage node, compounds like MOTS-c function as mitochondrial-derived peptides that regulate nuclear gene expression directly under metabolic stress. Similarly, direct pharmacological agents like AICAR activate AMP-activated protein kinase (AMPK) downstream of energy depletion, and synthetic agonists like GW501516 target nuclear PPAR-delta receptors to induce gene transcription.
Unlike direct agonists that bypass initial cellular control checkpoints, 5-Amino-1MQ alters endogenous metabolite availability (NAM and SAM), allowing the cell to modulate its own sirtuin and AMPK pathways naturally. This distinctive mode of action makes 5-Amino-1MQ an exceptional tool for comparative metabolic studies, enabling investigators to differentiate between enzyme-inhibition-driven NAD+ restoration and receptor-mediated transcriptomic upregulation across various tissue models. Laboratories establishing broader metabolic screens often procure these compounds via wholesale research accounts for parallel assay testing.
Analytical Standards and Reagent Integrity in Preclinical Studies
To achieve reproducible bioenergetic data in cell culture and animal models, researchers must utilize high-purity chemical reagents free from synthetic impurities or heavy metal contamination. Small-molecule NNMT inhibitors synthesized with residual reagents can cause non-specific cytotoxicity in delicate primary adipocyte or hepatocyte cultures.
PX1 Research manufactures small molecules and peptides in state-of-the-art facilities, employing rigorous high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to verify molecular identity and purity (>98%). Every production batch undergoes comprehensive testing in an ISO 17025 accredited laboratory, ensuring strict compliance with endotoxin limits and solvent removal standards. Access complete batch documentations directly within our research repository.
Frequently Asked Questions
What is the primary molecular target of 5-Amino-1MQ in research models?
5-Amino-1MQ specifically targets and inhibits nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme responsible for converting nicotinamide (NAM) and S-adenosylmethionine (SAM) into 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH).
How does 5-Amino-1MQ increase intracellular NAD+ without direct NAD+ supplementation?
By inhibiting NNMT, 5-Amino-1MQ prevents the methylation and clearance of nicotinamide (NAM). The resulting intracellular accumulation of free NAM feeds directly into the NAMPT-mediated NAD+ salvage pathway, elevating intracellular NAD+ synthesis endogenously.
Is 5-Amino-1MQ approved for human consumption or clinical use?
No. 5-Amino-1MQ is a specialized chemical compound intended exclusively for laboratory in vitro and preclinical animal research use. It is not approved for human consumption, therapeutic use, or clinical administration.
What analytical tests are provided with PX1 Research's 5-Amino-1MQ?
Each lot of 5-Amino-1MQ from PX1 Research is verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm purity (>98%) and correct molecular weight. Lot-specific Certificates of Analysis (COA) are available for download.
How should 5-Amino-1MQ powder and stock solutions be stored in the lab?
Lyophilized or crystalline 5-Amino-1MQ powder should be stored tightly sealed at -20°C in a dry, dark environment. Once reconstituted in a suitable solvent (such as DMSO or sterile buffer), stock aliquots should be stored at -80°C to avoid repeated freeze-thaw cycles.
What is the typical IC50 range reported for 5-Amino-1MQ against NNMT?
In biochemical enzymatic assays using recombinant human and murine NNMT, 5-Amino-1MQ exhibits a reported IC50 in the low micromolar range, typically between 1.2 µM and 2.5 µM depending on substrate concentration and assay conditions.
How does 5-Amino-1MQ affect intracellular S-adenosylmethionine (SAM) levels?
By inhibiting NNMT, 5-Amino-1MQ blocks a major consumer of SAM in adipocytes and liver cells, preventing SAM depletion and preserving the SAM/SAH ratio required for histone and DNA methyltransferase activity.
What are PX1 Research's shipping procedures for laboratory orders?
PX1 Research dispatches research compounds standardly with same-day shipping for orders placed Monday through Friday before cut-off times. All orders ship directly from centralized fulfillment facilities located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.